Αποτελέσματα Αναζήτησης
30 Σεπ 2024 · SPDR ® S&P Biotech ETF earns a Morningstar Medalist Rating of Neutral with strength in areas such as People offset by weaker spots such as Process.
30 Σεπ 2024 · Review the latest XBI Morningstar rating and analysis on the ETF to determine if it is the right investment decision for your goals.
30 Σεπ 2024 · XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar.
1 ημέρα πριν · The top 10 holdings account for about 26.34% of total assets under management. Performance and Risk So far this year, XBI has added about 11.71%, and was up about 35.09% in the last one year (as ...
31 Οκτ 2024 · The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from...
24 Ιουν 2024 · Learn everything you need to know about SPDR® S&P Biotech ETF (XBI) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the...
Find the latest SPDR S&P Biotech ETF (XBI) stock quote, history, news and other vital information to help you with your stock trading and investing.
